APP and Alzheimer disease: Altogether, these data indicate that the decreased levels of ATP may reduce the abnormal interaction between Aβ and APP, leads to mitochondrial dysfunction, mitochondria supplying ATP to nerve terminals and boosts synaptic and cognitive function in AD.